HYGRASTIM Trademark

Trademark Overview


On Friday, June 21, 2019, a trademark application was filed for HYGRASTIM with the United States Patent and Trademark Office. The USPTO has given the HYGRASTIM trademark a serial number of 79265618. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, June 2, 2020. This trademark is owned by Genexine, Inc.. The HYGRASTIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; medicated candy; pharmaceuticals; pharmaceutical preparations for the treatment of inflammatory bowel disease; pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; agents for treating asthma; dermatological pharmaceutical products; antibi...
hygrastim

General Information


Serial Number79265618
Word MarkHYGRASTIM
Filing DateFriday, June 21, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, June 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; medicated candy; pharmaceuticals; pharmaceutical preparations for the treatment of inflammatory bowel disease; pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; agents for treating asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; antibody fusion protein for medical treatment; blood solvent; pharmaceutical preparations for the treatment of neutropenia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Sunday, June 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 2, 2021FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 2, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, February 13, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, June 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 28, 2020NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, March 25, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 25, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 25, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, March 25, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 25, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 25, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, October 19, 2019REFUSAL PROCESSED BY IB
Friday, September 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 27, 2019REFUSAL PROCESSED BY MPU
Saturday, September 14, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 13, 2019NON-FINAL ACTION WRITTEN
Thursday, September 12, 2019ASSIGNED TO EXAMINER
Tuesday, September 3, 2019APPLICATION FILING RECEIPT MAILED
Friday, August 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 22, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB